Clinical trials in Roskilde – page 80

1 178 clinical trials in Roskilde, Denmark across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in DenmarkKliniske-Forsoeg.dk

Roskilde at a glance

1 178

clinical trials

Research sites3

Quick filters

1 178 trials in Roskilde

Open in trial search

Idiopathic pulmonary fibrosis

Not recruiting

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Nerandomilast
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Osteochondrodysplasia

Not recruiting

Study on the Effects of Navepegritide and Lonapegsomatropin in Children with Achondroplasia

InvestigationalNo placebo

Study on the Effects of Navepegritide and Lonapegsomatropin in Children with Achondroplasia

InvestigationalNo placebo

Denmark

Participants:0–17 years
Substances:Lonapegsomatropin
Sponsor:Ascendis Pharma Growth Disorders A/S

Contact Research Centre

Alpha-1 antitrypsin deficiency+1

Not recruiting

Study Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

Registered drug

Study Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

Registered drug

Denmark

Participants:18–64 years · 65+ years
Sponsor:Sanofi AATD Inc.

Contact Research Centre

Osteoarthritis

Not recruiting

Study on the Effects of QUC398 for Patients with Knee Osteoarthritis

Registered drug

Study on the Effects of QUC398 for Patients with Knee Osteoarthritis

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Paracetamol
Sponsor:Novartis Pharma AG

Contact Research Centre

Dermatitis atopic

Not recruiting

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Registered drug

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Registered drug

Denmark

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

B-cell lymphoma+1

Not recruiting

Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma

Registered drugNo placebo

Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Ovarian cancer stage III

Not recruiting

Study on the Effect of Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Stage III Ovarian Cancer Patients Undergoing Surgery

Registered drugNo placebo

Study on the Effect of Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Stage III Ovarian Cancer Patients Undergoing Surgery

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Study of Lenvatinib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Cancer After Platinum and Immunotherapy Treatment

Registered drugNo placebo

Study of Lenvatinib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Cancer After Platinum and Immunotherapy Treatment

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

HIV infection+1

Not recruiting

Study on Semaglutide for Weight Loss in Patients with HIV and Obesity

Registered drugNo placebo

Study on Semaglutide for Weight Loss in Patients with HIV and Obesity

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:University College Dublin

Contact Research Centre

Ataxia telangiectasia

Not recruiting

Study on the Effects of EryDex (Dexamethasone Sodium Phosphate) for Children Aged 6-9 with Ataxia Telangiectasia

Investigational

Study on the Effects of EryDex (Dexamethasone Sodium Phosphate) for Children Aged 6-9 with Ataxia Telangiectasia

Investigational

Denmark

Participants:0–17 years · 18–64 years
Substances:Dexamethasone Sodium Phosphate
Sponsor:Quince Therapeutics S.p.A.

Contact Research Centre

Osteoarthritis

Not recruiting

Study on Apocynin and Paeonol for Knee Osteoarthritis Pain Relief in Adults

Registered drug

Study on Apocynin and Paeonol for Knee Osteoarthritis Pain Relief in Adults

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Apocynin
Sponsor:Akl Research & Development Limited

Contact Research Centre

Cutaneous T-cell lymphoma+3

Not recruiting

Study of Mogamulizumab and Total Skin Electron Beam Therapy for Patients with Stage IB-IIB Cutaneous T-Cell Lymphoma

Registered drugNo placebo

Study of Mogamulizumab and Total Skin Electron Beam Therapy for Patients with Stage IB-IIB Cutaneous T-Cell Lymphoma

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Mogamulizumab
Sponsor:European Organisation For Research And Treatment Of Cancer

Contact Research Centre

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Roskilde

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on endometrial carcinoma, non-small cell lung cancer, and chronic myeloid leukemia treatments. Studies evaluate novel therapeutic combinations and targeted approaches for better patient outcomes.

Advanced cancer therapies
Immunotherapy combinations
Molecular response studies

Ongoing investigations into personalized treatment approaches for various cancer types.

02 Cardiovascular Studies

Research focusing on heart failure prevention and cardiovascular disease management. Studies evaluate new treatments and combinations like baxdrostat with dapagliflozin.

Prevention strategies
Risk reduction therapies
Innovative drug combinations

Comprehensive trials aimed at improving cardiovascular outcomes in high-risk populations.

03 Immunology and Dermatology

Clinical investigations into atopic dermatitis, plaque psoriasis, and hidradenitis suppurativa. Evaluating new therapeutic options for chronic inflammatory conditions.

Inflammatory skin conditions
Novel biological therapies
Treatment efficacy studies

Advancing treatment options for patients with moderate to severe skin conditions.

04 Infectious Disease Research

Studies focusing on meningococcal immunization and viral infections. Investigating vaccine safety and efficacy in different age groups, from infants to adults.

Vaccine development
Immunogenicity studies
Prevention strategies

Important research advancing preventive medicine and infection control.

Back to Denmark All countries